Verdict against Bayer in Monsanto Roundup case is slashed to $25 million

Edwin Hardeman, shown in March with his wife, Mary, used Roundup herbicide and alleged that his years of exposure caused his non-Hodgkin’s lymphoma.
(Jeff Chiu / Associated Press)

Bayer won a ruling Monday that slashes a jury verdict to $25.3 million from $80.3 million in the second case to go to trial over claims that exposure to Roundup weedkiller causes cancer.

U.S. District Judge Vince Chhabria in San Francisco previously said the $75-million portion of the verdict intended to punish the company was too high based on legal precedent that punitive damages shouldn’t be more than nine times bigger than compensatory damages.

The judge said in an order Monday that although the jury’s decisions to award punitive damages was “reasonable,” the size of the award was “constitutionally impermissible.” On Friday he rejected the company’s request for a new trial.


The German company has vowed to keep defending its popular weedkiller after losing three trials since last summer, when it acquired Monsanto Co., which started making Roundup in the 1970s.

The case was brought by Edwin Hardeman, who used the herbicide on his large plot of land in Sonoma County, about 60 miles north of San Francisco. Like many of the other 13,400 consumers suing Bayer, Hardeman alleged that his years of exposure to the chemical caused his non-Hodgkin’s lymphoma. Bayer is scheduled for a fourth trial this summer in St. Louis, where Monsanto had its headquarters.

Chhabria is handling the collection of hundreds of federal suits over Roundup. In May, he appointed mediator Ken Feinberg to try to work out a settlement.